Osaka, Japan

Norihiko Sugimoto

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fuso Pharmaceutical Industries, Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norihiko Sugimoto. Retrieved from https://idiyas.com/inventor/norihiko-sugimoto-0tyk7t18

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Norihiko Sugimoto: Innovator in Nucleic Acid Detection

Introduction

Norihiko Sugimoto is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of nucleic acid detection, showcasing his expertise through innovative methodologies and devices.

Latest Patents

Sugimoto holds a patent for a "Nucleic acid detection or quantification method using mask oligonucleotide, and device for same." This invention enables very simple and highly sensitive detection or quantification of target nucleic acids. The method involves hybridizing mask oligonucleotides to specific regions in a single-stranded nucleic acid, which stabilizes the target while allowing for effective probe hybridization. This technique is further enhanced by subjecting the nucleic acid to chromatography, resulting in improved detection capabilities.

Career Highlights

Sugimoto is associated with Fuso Pharmaceutical Industries, Ltd., where he applies his innovative techniques to advance the field of molecular diagnostics. His work has garnered attention for its potential applications in various medical and research settings.

Collaborations

Some of his notable coworkers include Souji Eda and Masahiro Asakura, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Norihiko Sugimoto's contributions to nucleic acid detection represent a significant advancement in the field, highlighting the importance of innovation in medical diagnostics. His work continues to influence research and applications in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…